Sharemaestro company-news research for Pro Medicus Limited (PME), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
ASX
Australia
Measured evidence
Company news sentiment
PME news sentiment
Pro Medicus Limited
Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.
Weighted tone50Neutral is 50
Balanced news tone
36/100 evidence confidence
100% direct company focus
1 current stories across 1 publishers
Current company news
Price moving ahead of tone
Balanced news tone is drawn from 1 fresh independent stories, including 1 company-specific items across 1 publishers.
Latest source headline What Keeps Pro Medicus (ASX:PME) in Growth Focus? Kalkine Media · 07 Aug 2026 04:32What supports the read
1 current stories are mapped specifically to PME.
What tempers the read
Only 1 publisher currently contribute to the measured read.
Price is moving more forcefully than the current news tone suggests.
50/100
Weighted toneBalanced news tone
36/100
Evidence confidencethin evidence
100%/100
Company focus1 direct stories
N/A/100
Evidence agreementrequires at least 2 stories
News history
Tone and story flow over 21 days
24 Jul03 Aug13 Aug
Weighted toneStory volumeNeutral 50
Evidence confidence
What supports the score
Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.
Sample depth12
1.0 effective storiesSource breadth20
1 independent publishersDirect relevance100
company-specific evidence shareFreshness34
recency-weighted evidenceAgreement0
requires at least 2 storiesSource independence0
lower publisher concentrationPrice context
Sentiment against the 26-week price path
Price is moving more forcefully than the current news tone suggests.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
News subjects
What is shaping the score
Market update501 stories · 100%
Source mix
Where the evidence comes from
Kalkine Media501 stories · 100%
Recurring subjects
Subjects appearing most often
Topic structure will appear when classified tags are present in the current feed.
Earlier readings
How the score has changed
ConstructiveBalanced or withheldCautious
Source headlines
The news behind the score
Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.
#150Tone
Kalkine MediaDirect company coverage
What Keeps Pro Medicus (ASX:PME) in Growth Focus?
- Published
- 07 Aug 2026 04:32
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Earlier company news
PME news archive
Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above.
Aug
02
2026
Kalkine MediaArchivedNeutral tone
What Makes Pro Medicus (ASX:PME) A Key Healthcare Market Indicator?
- Published
- 2 Aug 2026 02:46
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Aug
01
2026
Kalkine MediaArchivedNeutral tone
Why Does Pro Medicus (ASX:PME) Still A Growth Gauge?
- Published
- 1 Aug 2026 01:01
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
29
2026
Kalkine MediaArchivedNeutral tone
Why Is Pro Medicus Momentum Reflects ASX Health-Tech Appeal (ASX:PME) Shares?
- Published
- 29 Jul 2026 02:04
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
24
2026
Kalkine MediaArchivedNeutral tone
Could Pro Medicus (ASX:PME) Be Approaching a Crucial Healthcare Moment?
- Published
- 24 Jul 2026 11:00
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
23
2026
KalkineArchivedNeutral tone
Pro Medicus (ASX:PME) Is Down Sharply Today — Should Investors Reassess the Medical Imaging Software Leader?
- Published
- 23 Jul 2026 22:03
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
23
2026
thebull.com.auArchivedNeutral tone
Pro Medicus Shares Continue To Break Lower: The Latest
- Published
- 23 Jul 2026 11:37
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
22
2026
KalkineArchivedNeutral tone
Pro Medicus (ASX:PME) Falls — Is the ASX Market Favourite Finally Facing a Reality Check?
- Published
- 22 Jul 2026 22:49
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
19
2026
Kalkine MediaArchivedPositive tone
Pro Medicus (ASX:PME) in Focus: What Could Healthcare Results Reveal?
- Published
- 19 Jul 2026 19:52
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
16
2026
Kalkine MediaArchivedPositive tone
What Keeps Pro Medicus (ASX:PME) at the Centre of Growth Screens?
- Published
- 16 Jul 2026 09:36
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
09
2026
Kalkine MediaArchivedNeutral tone
Pro Medicus (ASX:PME) Shares Move On New AI Cardiology Tie-Up
- Published
- 9 Jul 2026 18:11
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
06
2026
simplywall.stArchivedNeutral tone
Why Pro Medicus (ASX:PME) Is Up 11.0% After New US Visage Imaging Contract Wins – And What's Next
- Published
- 6 Jul 2026 07:45
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
05
2026
Kalkine MediaArchivedNeutral tone
Why Is Pro Medicus (ASX:PME) Back in the Spotlight as the ASX 200 Recovers?
- Published
- 5 Jul 2026 10:34
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
02
2026
Kalkine MediaArchivedNeutral tone
Why NEXTDC (ASX:NXT) And Pro Medicus (ASX:PME) Are Rewriting The ASX Tech Story
- Published
- 2 Jul 2026 10:45
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
01
2026
Kalkine MediaArchivedNeutral tone
Why Pro Medicus (ASX:PME) Is Back in Focus After a Landmark US Deal
- Published
- 1 Jul 2026 00:37
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
29
2026
KalkineArchivedNeutral tone
Pro Medicus (ASX:PME) — Why ASX Medical AI Is Back in the Spotlight
- Published
- 29 Jun 2026 11:29
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
28
2026
KalkineArchivedNeutral tone
Pro Medicus (ASX:PME): Pro Medicus Keeps Defying Gravity as Health-Tech Investors Watch Closely
- Published
- 28 Jun 2026 01:31
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
27
2026
Bez KabliArchivedNeutral tone
Pro Medicus rally flips Echo IQ’s A$20 million deal into a A$1 billion signal
- Published
- 27 Jun 2026 05:38
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
26
2026
Kalkine MediaArchivedNeutral tone
Why Pro Medicus (ASX:PME) Keeps Winning in Health Tech?
- Published
- 26 Jun 2026 14:05
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
26
2026
Bez KabliArchivedNeutral tone
Pro Medicus (ASX:PME) up A$669m in market cap after Echo IQ (ASX:EIQ) AI agreement
- Published
- 26 Jun 2026 11:42
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
25
2026
Bez KabliArchivedPositive tone
Pro Medicus up 3.5% on heavy trade after dropping out of ASX 50
- Published
- 25 Jun 2026 01:25
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
22
2026
Bez KabliArchivedPositive tone
Pro Medicus (ASX:PME) gains after leaving ASX 50, mid-cap ETF demand seen
- Published
- 22 Jun 2026 22:11
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
22
2026
simplywall.stArchivedNeutral tone
Pro Medicus (ASX:PME) Shares Could Be 11.3% Undervalued After Index Exit And US Wins
- Published
- 22 Jun 2026 18:53
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
20
2026
KalkineArchivedPositive tone
Is Pro Medicus (ASX:PME) Worth Adding to Your Watchlist?
- Published
- 20 Jun 2026 22:32
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
20
2026
Bez KabliArchivedNeutral tone
Pro Medicus jumps 3.1% to A$172.80 ahead of ASX 50 removal
- Published
- 20 Jun 2026 10:13
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.